ITEMS IN AFP WITH KEYWORD:
Aug 1, 2007 Issue
Alpha-glucosidase Inhibitors May Reduce the Risk of Type 2 Diabetes [Cochrane for Clinicians]
The literature shows that acarbose can reduce the risk of type 2 diabetes in patients with impaired glucose tolerance or impaired fasting glucose. However, it is unclear whether the drug stops or delays the development of the disease or masks the diagnosis. There is no evidence that acarbose use red...
Home monitoring of blood glucose and blood pressure levels can provide patients and physicians with valuable information in the management of diabetes mellitus and hypertension. Home monitoring allows patients to play an active role in their care and may improve treatment adherence and clinical outc...
The American Diabetes Association currently recommends an A1C goal of less than 7 percent. However, many patients are unable to achieve this goal by using oral drug combinations or diet and exercise, leaving insulin as the only treatment option. In most cases, insulin is initiated later in therapy b...
Inhaled insulin provides an alternative route of administration for rapid-acting insulin but offers no other benefit over available insulin therapy. It may reduce, but not eliminate, the need for self-injection in patients with type 1 diabetes. In patients with type 2 diabetes, the risk of hypoglyce...
Feb 1, 2007 Issue
The Role of Exercise in Patients with Type 2 Diabetes [Cochrane for Clinicians]
Regular exercise reduces A1C levels, adiposity, and triglyceride levels. However, no research has definitively proved a benefit of exercise on patient-oriented outcomes such as diabetes-related morbidity and mortality.
Jan 15, 2007 Issue
CDC Releases Data on Visual Impairment in Patients with Diabetes [Practice Guidelines]
The Centers for Disease Control and Prevention (CDC) has released data on visual impairment in patients with diabetes. Patients with diabetes are more likely to be visually impaired than those who do not have the disease.
Pregabalin is safe and effective for the management of neuropathic pain associated with diabetic peripheral neuropathy. Drawbacks include the cost and the lack of studies demonstrating equivalence or superiority to other treatments. However, pregabalin’s ease of dosing titration, minimal drug intera...
Tight control of blood glucose levels and risk factors for cardiovascular disease (e.g., hypertension, hypercholesterolemia) can substantially reduce the incidence of microvascular and macrovascular complications from type 1 diabetes. Physicians play an important role in helping patients make essent...
Sep 1, 2006 Issue
ADA Releases Standards of Medical Care for Patients with Diabetes [Practice Guidelines]
The American Diabetes Association (ADA) has published a position statement containing evidence-based recommendations for diabetes care, treatment goals, and tools to evaluate the quality of care.
Aug 15, 2006 Issue
CDC Reports on End-stage Renal Disease in Patients with Diabetes [Practice Guidelines]
The Centers for Disease Control and Prevention (CDC) has released a report detailing the incidence of end-stage renal disease (ESRD) in patients with diabetes. Diabetes mellitus is the leading cause of ESRD in the United States, accounting for 44 percent of new cases in 2002.